Uncomplicated Nausea and Vomiting in the Emergency Department
NCT00778011 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 137
Last updated 2012-06-28
Summary
Nausea and vomiting is a common complaint in the emergency department. Treatment is important for many reasons. In addition to patient comfort, there are adverse effects secondary to vomiting such as dehydration, metabolic alkalosis, Mallory-Weiss tears, and aspiration. Two mediations common used for nausea in ED patients include Ondanesetron and Metoclopramide.
Conditions
Interventions
- DRUG
-
Ondansetron
dosage
- DRUG
-
Ondansetron
4 mg
- DRUG
-
Metoclopramide
10 mg IV
Sponsors & Collaborators
-
WellSpan Health
lead OTHER
Principal Investigators
-
Marc Pollack, MD, PhD · York Hospital Emergency Department Physician
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-11-30
- Primary Completion
- 2006-12-31
- Completion
- 2006-12-31
Countries
- United States
Study Locations
More Related Trials
-
Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)
NCT03125811 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting
NCT03297021 ·Status: COMPLETED ·Phase: PHASE4
-
Symptomatic Treatment of Acute Gastroenteritis
NCT01257672 ·Status: COMPLETED ·Phase: PHASE3
-
Antiemetic Efficacy of Ondansetron Versus Metoclopramide
NCT02619201 ·Status: UNKNOWN ·Phase: PHASE3
-
Ondansetron Combined with Dyclonine Hydrochloride to Improve Patient Experience in Unsedated Esophagogastro-duodenoscopy
NCT06729307 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
The Efficacy of B6 and Metoclopramide Combination in Comparison With the Other Antiemetics
NCT06390787 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
the Efficacy and Safety of Ondansetron Oral Soluble Pellicles
NCT06282211 ·Status: RECRUITING ·Phase: PHASE3
-
Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis in a Pediatric Emergency Department
NCT00120744 ·Status: COMPLETED ·Phase: NA
-
Ondansetron VS Doxylamine and Pyridoxine in Treating Nausea of Pregnancy
NCT01668069 ·Status: COMPLETED ·Phase: NA
-
Isopropyl Alcohol vs Ondansetron for Nausea in the Emergency Department
NCT02760069 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Ondansetron During Intramuscular Ketamine Use in Children: A Trial in Emergency Department
NCT01477242 ·Status: UNKNOWN ·Phase: NA
-
Ondansetron Reduce Vomiting Associated With Ketamine PSA
NCT00387556 ·Status: COMPLETED ·Phase: NA
-
The Montefiore Metoclopramide Study
NCT00475306 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Study on the Efficacy and Safety of Ondansetron Oral Membrane for the Prevention of Vomiting During Moderate Hypoemetic Chemotherapy
NCT06371014 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety of the Administration of Ondansetron Versus Habitual Clinical Practice for the Treatment of Vomiting in Children With Mild and Moderate Dehydration: Randomized Clinical Trial
NCT04318847 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Ondansetron on Vomiting Due to Acute Gastroenteritis in Pediatric During Winter
NCT02028910 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo
NCT02253524 ·Status: COMPLETED ·Phase: PHASE4
-
Ondansetron Oral Versus Orally Disintegrating Tablets (ODT)
NCT02174874 ·Status: COMPLETED
-
Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer
NCT00020657 ·Status: COMPLETED ·Phase: PHASE3
-
Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting
NCT02473887 ·Status: COMPLETED ·Phase: PHASE1
-
Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients
NCT00600990 ·Status: COMPLETED ·Phase: PHASE2
-
Triage Administration of Ondansetron for Gastroenteritis in Children
NCT03052361 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Efficacy Study of IV Fluids Only vs Ondansetron to Treat Dehydration
NCT00691275 ·Status: WITHDRAWN ·Phase: NA
-
Oral Ondansetron to Improve Patient Experience of Unsedated Esophagogastroduodenoscopy Pilot Study
NCT07264738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis
NCT03851835 ·Status: COMPLETED ·Phase: PHASE3